Search

Eyewire News: The Podcast

Eyewire News: The Podcast

05.06.26

Bayer Acquires Perfuse in $2.45 Billion Deal

Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

05.06.26

Bayer Acquires Perfuse in $2.45 Billion Deal

04.29.26

How Ophthalmology Strategics are Rewriting the Playbook

04.22.26

Glaukos Issued J-Code for Recently Launched Epioxa

04.15.26

Breaking News from the ASCRS Meeting in Washington DC

04.08.26

More than 3 Million Bottles of Eye Drops Recalled

04.01.26

Biogen Enters GA Treatment Market After Major Acquisition

03.25.26

Interview with ASCRS Executive Director Steve Speares

03.18.26

Alcon and Lensar Call Off Merger

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D